Quantcast

Michigan Lawyer Discusses Lawsuits For Meningitis From Receiving Steroid Injection

October 16, 2012

The medical malpractice lawyers at Buckfire & Buckfire, P.C. are actively investigating the legal rights of patients who have been injured or died due to the meningitis outbreak due to steroid injections. Call now at (800) 606-1717 for a free legal consultation.

Southfield, Michigan (PRWEB) October 16, 2012

The recent outbreak of meningitis of patients infected by steroid injections has caused a significant number of injuries and deaths throughout the United States. Our Michigan medical malpractice attorneys are actively investigating the legal rights of patients who have been injured or died due to the recent and ongoing meningitis outbreak due to steroid injections.

According to NBC News, nearly 14,000 patients have been given this potentially tainted injection of pain medicine. The injections were shipped to 23 different states, including the State of Michigan. Of the 14,000 people at risk of infection, medical practitioners are trying to reach about 2,000 patients to warn them to get tested immediately.

Federal and State health authorities have confirmed that since people that began coming to emergency rooms in the last month in the State of Tennessee, there have been 14 meningitis deaths.

In addition, the number of people who contracted meningitis caused by steroid injections has also increased dramatically this week, reaching 169 infected patients on Thursday. This number was an increase of 32 from the day before.

All infected patients received injection with preservative-free methylprednisolone acetate prepared by New England Compounding Center (NECC), located in Framingham, MA. The lots of medication that were used on infected patients have been recalled. The lots are:

  • Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #05212012@68, BUD 11/17/2012
  • Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #06292012@26, BUD 12/26/2012
  • Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #08102012@51, BUD 2/6/2013

Although the U.S. Centers for Disease Control and Prevention (CDC) said on Thursday it is working on containing the meningitis outbreak, eleven out of the 23 states in which the medication was shipped to have reported cases of meningitis, including deaths in six states.

In addition, the CDC is concerned that the injection may not be limited to epidural injections, but injections in the joints, such as a knee or ankle, as well as it was recently disclosed that a Michigan patient did receive an injection in the ankle and has developed an infection.

“Our medical malpractice attorneys in Michigan are actively investigating the legal rights of patients who have been injured or died due to the meningitis outbreak due to epidural steroid injections. If a family member died due to the meningitis from a steroid injection, the surviving family members may be able to file a Wrongful Death Lawsuit or make a claim under the National Vaccine Injury Protection Act.

To learn more about your legal right, any individual who believes they have been a victim of this outbreak should contact an experienced medical malpractice attorney immediately to discuss their case,” says Firm Partner and Trial Attorney, Daniel Buckfire.

About Buckfire & Buckfire, P.C.

Buckfire & Buckfire, P.C. is a Michigan based law firm specializing in medical malpractice cases. The firm has earned the highest possible rating in the legal profession for ability and integrity and are rated “Superb” by the top internet lawyer rating service. For over forty years, Buckfire & Buckfire, P.C. has earned the trust of Michigan injury and accident victims to win their case. The medical malpractice attorneys at Buckfire & Buckfire, P.C. will represent you in your meningitis case under their No Fee Promise, meaning no legal fees until the case is won.

To learn more about the award winning medical malpractice attorneys call toll free at (800) 606-1717 or visit http://www.BuckfireLaw.com

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/10/prweb10010361.htm


Source: prweb



comments powered by Disqus